Clinical trials
Phase 3 Obesity trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 11 |
| 2024 | 10 |
| 2025 | 17 |
| 2026 | 36 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
| Completed | 25 |
| Not yet recruiting | 13 |
| Active, not recruiting | 11 |
| Unknown status | 7 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 20 |
| Novo Nordisk A/S | 9 |
| Boehringer Ingelheim | 5 |
| Hangzhou Sciwind Biosciences Co., Ltd. | 5 |
| AstraZeneca | 4 |
| Gan & Lee Pharmaceuticals. | 4 |
| Innovent Biologics (Suzhou) Co. Ltd. | 4 |
| Xiangya Hospital of Central South University | 4 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 91 |
| Overweight | 54 |
| Diabetes Mellitus, Type 2 | 13 |
| Sleep Apnea, Obstructive | 10 |
| Weight Loss | 4 |
| Nutrition Disorders | 3 |
| Body Weight | 2 |
| Heart Failure | 2 |
| Osteoarthritis | 2 |
| Arthritis | 1 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.